We have exciting news to share! Last month, our team took the initiative to protect more of our groundbreaking intellectual property and filed a provisional patent application with the U.S. Patent and Trademark Office. This patent application, #62/962,337, is the second such one that’s been filed over the last year. The other application, #62/845,162, is for “Compositions and Methods for Organ Printing.” You may be thinking, what exactly does this mean?
Without a doubt, this represents a significant step toward our journey of 3D bioprinting a functional mini-heart. These patents are crucial for protecting the intellectual property around our process for printing complex structures through bioprinting with soft tissues, and also increasing our arsenal of bioinks that can be used for printing. Creating an IP portfolio illustrates that we are not only progressing in the lab, but that the technology we are creating is worthy of this protection. With that, this is a significant way to create shareholder value, by building IP that only the company holds and protecting our technological advancements.
At BIOLIFE4D, we will continue to develop technology in-house throughout our entire journey. Once this technology has matured to an advanced state, we will continue to seek additional protection from the U.S. patent office. The importance of this protection and the value it brings to the Company cannot be understated. We are truly proud of the progress we’ve made so far and can’t wait to share more updates while we’re on our way toward bioprinting a human heart viable for transplant.
— Team at BIOLIFE4D